Cas:214535-51-0 2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride manufacturer & supplier

Chemical Name:2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride

CAS.NO:214535-51-0

Synonyms:2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride

Molecular Formula:C₁₃H₂₀Cl₂N₂O₂

Molecular Weight:307.21600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:439.9ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:43.78000

Exact Mass:306.09000

LogP:2.36860

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride Use and application,2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride technical grade,usp/ep/jp grade.

Related News: FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. 2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride manufacturer FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. 2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride supplier The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride vendor At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 2-(4-benzylpiperazin-1-yl)acetic acid,dihydrochloride factory FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost.